6-Maleimidocaproic Acid: Powering Bioconjugation and Advanced Therapeutics
A versatile chemical linker enabling precise biomolecule conjugation for cutting-edge research and development.
Get a Quote & SampleProduct Core Value
6-Maleimidocaproic Acid
6-Maleimidocaproic acid is a critical bifunctional linker widely used in advanced chemical synthesis and biotechnology. Its dual functionality, featuring a reactive maleimide group and a terminal carboxylic acid, allows for precise and stable conjugation of biomolecules. This makes it an indispensable tool for researchers in drug development, diagnostics, and material science, facilitating the creation of novel therapeutics and advanced materials.
- Unlock targeted therapies by leveraging the 6-Maleimidocaproic acid for bioconjugation, precisely linking therapeutic agents to specific biological targets.
- Achieve stable amide bond formation with carboxylic acid amine reaction capabilities, a key step in creating complex bioconjugates.
- Facilitate precise protein PEGylation reagent applications, enhancing the pharmacokinetic properties of therapeutic proteins.
- Drive innovation in antibody drug conjugate linkers, enabling more effective and targeted cancer treatments.
Key Advantages
Versatile Bifunctionality
The unique combination of a maleimide group for thiol reactivity and a carboxylic acid for amine coupling makes this compound highly versatile for various bioconjugation strategies.
Stable Linkages
Forms robust thioether bonds with thiols and stable amide bonds with amines, ensuring the integrity and efficacy of the conjugated molecules.
Enabling Drug Development
Crucial for the 6-Maleimidocaproic acid applications in designing Antibody-Drug Conjugates (ADCs), leading to more targeted and potent cancer therapies.
Key Applications
Bioconjugation
Serves as a fundamental component in 6-Maleimidocaproic acid for bioconjugation protocols, linking peptides, proteins, and other molecules for research and therapeutic purposes.
Drug Delivery Systems
Essential for the 6-Maleimidocaproic acid applications in developing advanced drug delivery systems, particularly Antibody-Drug Conjugates (ADCs), to improve treatment specificity.
Diagnostics
Utilized in the creation of diagnostic assays and imaging agents, facilitating the attachment of detection molecules to targeted biomarkers.
Protein Modification
A key reagent for protein PEGylation reagent applications, enhancing the solubility, stability, and circulation time of therapeutic proteins.